Delivery Order SPE2D021DA002-SPE2D325F082D

Award Date 5/27/25
Potential Completion Date 5/30/25
Potential Value $1.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,472.55, is for the delivery of ADACEL TDAP VIAL, a pharmaceutical product. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of ADACEL TDAP VIAL 0.5ML. The contract has a firm fixed price of $1,821.96 and a completion date of June 13, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products to federal agencies, including the Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,518.30, is for the delivery of ADACEL TDAP VIAL, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract has an ultimate completion date of April 2, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,219.04 delivery order is for the supply of ADACEL TDAP VIAL, with a completion date of June 20, 2024. The order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ADACEL TDAP VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $1,214.64 and an ultimate completion date of June 6, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,523.80, is for the delivery of ADACEL TDAP Vial, a pharmaceutical product. The award is issued as a delivery order under a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999. This single-award IDC, under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Adacel TDAP vial. The firm fixed price contract has a potential value of $1,724.64 and a performance period through August 26, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,437.20 order is for the supply of the pharmaceutical product ADACEL TDAP VIAL. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) with the DLA Troop Support Medical to provide a wide range of pharmaceutical and medical supplies, such as flumazenil injection, prednisone...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $1,734.48 and a completion date of August 10, 2023. The order is for the supply of Adacel Tdap Vial, a pharmaceutical product, to support the medical needs of the U.S. military. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple indefinite delivery contracts...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,299.52 order is for the supply of the pharmaceutical product ADACEL TDAP VIAL. DMS Pharmaceutical Group has been a long-standing supplier of pharmaceuticals and medical products to the Department of Defense, holding multiple contracts and indefinite delivery vehicles to provide a variety of pharmaceutical items to...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F082D
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,568,380,483 units of ADACEL TDAP VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $1,518.30 and a completion date of May 30, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for pharmaceutical products. This contract award does not have a set-aside designation.

Generated 8/31/25, 12:56 AM